Senior insider sale
SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$199.3K
34.84K shares
What this filing means
YOUNG RICHARD A plans to sell 34.84K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $199.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/28/2024ACC: 0001973141-24-000326
Director
Since Jun 2019
34.84K
Shares to sell
$199.3K
Approx. market value
34.84K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
RSU Vesting
NA
9/16/2022
2.67KStock Award
NA
8/8/2012
32.17KTotal acquired34.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2022 | RSU Vesting NA | 2.67K | — |
8/8/2012 | Stock Award NA | 32.17K | — |
| Total | 34.84K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
34.84K
Market value
$199.3K
6/28/2024
Total
Units
34.84K
Value
$199.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/28/2024 | 34.84K | $199.3K | Nasdaq | Planned |
| Total | 34.84K | $199.3K | ||